Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Intermittent Pseudomonas Aeruginosa in Cystic Fibrosis
NCT00411736Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- May 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of azithromycin in cystic fibrosis (CF), Pseudomonas aeruginosa infection, sponsored by Rigshospitalet. Started May 2008; status: completed.
02
Drugs
azithromycin
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT00411736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411736.